{"id":50525,"date":"2025-12-18T19:18:44","date_gmt":"2025-12-18T10:18:44","guid":{"rendered":"https:\/\/www.marketresearch.jp\/reports\/?p=50525"},"modified":"2026-09-25T19:46:24","modified_gmt":"2026-09-25T10:46:24","slug":"seborrheic-dermatitis-treatment-market","status":"publish","type":"post","link":"https:\/\/www.marketresearch.jp\/reports\/seborrheic-dermatitis-treatment-market\/","title":{"rendered":"\u4e16\u754c\u306e\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\uff1a\u5264\u5f62\uff08\u30af\u30ea\u30fc\u30e0\u3001\u30d5\u30a9\u30fc\u30e0\u3001\u30b2\u30eb\uff09\u3001\u6cbb\u7642\u6cd5\uff08\u5185\u670d\u6cbb\u7642\u3001\u5149\u7dda\u7642\u6cd5\u3001\u5916\u7528\u6cbb\u7642\uff09\u3001\u85ac\u52b9\u5206\u985e\u3001\u88fd\u54c1\u30bf\u30a4\u30d7\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225 – \u4e16\u754c\u5e02\u5834\u4e88\u6e2c2025-2032\u5e74"},"content":{"rendered":"

\"Market<\/p>\n

\u4ee5\u4e0b\u306b\u3001\u3054\u6307\u5b9a\u306e\u968e\u5c64\u69cb\u9020\u3068\u7ffb\u8a33\u3067\u76ee\u6b21\u3092\u4f5c\u6210\u3057\u307e\u3059\u3002<\/p>\n

—<\/p>\n

**\u76ee\u6b21**<\/p>\n

1. **\u5e8f\u6587** (Preface)
\n2. **\u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3068\u30ab\u30d0\u30ec\u30c3\u30b8** (Market Segmentation & Coverage)
\n3. **\u8abf\u67fb\u5bfe\u8c61\u5e74** (Years Considered for the Study)
\n4. **\u901a\u8ca8** (Currency)
\n5. **\u8a00\u8a9e** (Language)
\n6. **\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc** (Stakeholders)
\n7. **\u8abf\u67fb\u65b9\u6cd5** (Research Methodology)
\n8. **\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc** (Executive Summary)
\n9. **\u5e02\u5834\u6982\u8981** (Market Overview)
\n10. **\u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8** (Market Insights)
\n 10.1. \u52b9\u80fd\u5411\u4e0a\u306e\u305f\u3081\u306e\u65b0\u898f\u5f90\u653e\u6027\u30ca\u30ce\u7c92\u5b50\u914d\u5408\u5e02\u8ca9\u6297\u771f\u83cc\u30b7\u30e3\u30f3\u30d7\u30fc\u306e\u9700\u8981\u5897\u52a0 (Increased demand for over-the-counter antifungal shampoos with novel sustained release nanoparticles for improved efficacy)
\n 10.2. \u76ae\u819a\u83f2\u8584\u5316\u30ea\u30b9\u30af\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u305f\u3081\u306e\u975e\u30b9\u30c6\u30ed\u30a4\u30c9\u6027\u6297\u708e\u75c7\u5316\u5408\u7269\u3092\u5229\u7528\u3057\u305f\u51e6\u65b9\u5c40\u6240\u30b3\u30eb\u30c1\u30b3\u30b9\u30c6\u30ed\u30a4\u30c9\u4ee3\u66ff\u54c1\u306e\u6210\u9577 (Growth of prescription topical corticosteroid alternatives leveraging non-steroidal anti-inflammatory compounds to minimize skin thinning risks)
\n 10.3. \u8102\u6f0f\u6027\u76ae\u819a\u708e\u306e\u7a4f\u3084\u304b\u306a\u7ba1\u7406\u306e\u305f\u3081\u306e\u30c6\u30a3\u30fc\u30c4\u30ea\u30fc\u30aa\u30a4\u30eb\u3084\u30d4\u30ea\u30c6\u30a3\u30aa\u30f3\u4e9c\u925b\u306a\u3069\u306e\u5929\u7136\u304a\u3088\u3073\u690d\u7269\u7531\u6765\u6210\u5206\u88fd\u5264\u306e\u62e1\u5927 (Expansion of natural and plant-derived ingredient formulations such as tea tree oil and zinc pyrithione for gentle seborrheic dermatitis management)
\n 10.4. \u982d\u76ae\u306e\u72b6\u614b\u306e\u30ea\u30e2\u30fc\u30c8\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3068\u500b\u5225\u5316\u3055\u308c\u305f\u6cbb\u7642\u9075\u5b88\u30b5\u30dd\u30fc\u30c8\u306e\u305f\u3081\u306e\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u7d71\u5408 (Integration of digital health platforms for remote monitoring of scalp condition and personalized treatment adherence support)
\n 10.5. \u85ac\u7269\u76f8\u4e92\u4f5c\u7528\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u4f4e\u6e1b\u3057\u305f\u5168\u8eab\u6027\u9175\u6bcd\u904e\u5897\u6b96\u3092\u6a19\u7684\u3068\u3059\u308b\u7d4c\u53e3\u6297\u771f\u83cc\u7642\u6cd5\u306e\u9032\u6b69 (Advancements in oral antifungal therapies targeting systemic yeast overgrowth with reduced drug interaction profiles)
\n 10.6. \u5065\u5eb7\u306a\u982d\u76ae\u30de\u30a4\u30af\u30ed\u30d0\u30a4\u30aa\u30fc\u30e0\u306e\u30d0\u30e9\u30f3\u30b9\u3092\u56de\u5fa9\u3059\u308b\u305f\u3081\u306e\u30d7\u30ec\u30d0\u30a4\u30aa\u30c6\u30a3\u30af\u30b9\u3001\u30d7\u30ed\u30d0\u30a4\u30aa\u30c6\u30a3\u30af\u30b9\u3001\u6297\u771f\u83cc\u5264\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u4f75\u7528\u7642\u6cd5\u306e\u51fa\u73fe (Emergence of combination therapies blending prebiotics probiotics and antifungal agents to restore healthy scalp microbiome balance)
\n 10.7. \u81e8\u5e8a\u7684\u6709\u52b9\u6027\u30c7\u30fc\u30bf\u306b\u88cf\u6253\u3061\u3055\u308c\u305f\u7121\u9999\u6599\u30fb\u30d1\u30e9\u30d9\u30f3\u30d5\u30ea\u30fc\u306e\u8102\u6f0f\u6027\u76ae\u819a\u708e\u88fd\u54c1\u306b\u5bfe\u3059\u308b\u6d88\u8cbb\u8005\u306e\u55dc\u597d\u306e\u9ad8\u307e\u308a (Increasing consumer preference for fragrance-free and paraben-free seborrheic dermatitis products backed by clinical efficacy data)
\n11. **2025\u5e74\u306e\u7c73\u56fd\u95a2\u7a0e\u306e\u7d2f\u7a4d\u7684\u5f71\u97ff** (Cumulative Impact of United States Tariffs 2025)
\n12. **2025\u5e74\u306e\u4eba\u5de5\u77e5\u80fd\u306e\u7d2f\u7a4d\u7684\u5f71\u97ff** (Cumulative Impact of Artificial Intelligence 2025)
\n13. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u88fd\u5264\u5225** (Seborrheic Dermatitis Treatment Market, by Formulation)
\n 13.1. \u30af\u30ea\u30fc\u30e0 (Cream)
\n 13.1.1. \u30b7\u30af\u30ed\u30d4\u30ed\u30c3\u30af\u30b9\u30af\u30ea\u30fc\u30e0 (Ciclopirox Cream)
\n 13.1.2. \u30b3\u30fc\u30eb\u30bf\u30fc\u30eb\u30af\u30ea\u30fc\u30e0 (Coal Tar Cream)
\n 13.1.3. \u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb\u30af\u30ea\u30fc\u30e0 (Ketoconazole Cream)
\n 13.2. \u30d5\u30a9\u30fc\u30e0 (Foam)
\n 13.3. \u30b2\u30eb (Gel)
\n 13.4. \u30ed\u30fc\u30b7\u30e7\u30f3 (Lotion)
\n 13.4.1. \u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb\u30ed\u30fc\u30b7\u30e7\u30f3 (Ketoconazole Lotion)
\n 13.4.2. \u30b5\u30ea\u30c1\u30eb\u9178\u30ed\u30fc\u30b7\u30e7\u30f3 (Salicylic Acid Lotion)
\n 13.5. \u30b7\u30e3\u30f3\u30d7\u30fc (Shampoo)
\n 13.5.1. \u30b7\u30af\u30ed\u30d4\u30ed\u30c3\u30af\u30b9\u30b7\u30e3\u30f3\u30d7\u30fc (Ciclopirox Shampoo)
\n 13.5.2. \u30b3\u30fc\u30eb\u30bf\u30fc\u30eb\u30b7\u30e3\u30f3\u30d7\u30fc (Coal Tar Shampoo)
\n 13.5.3. \u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb\u30b7\u30e3\u30f3\u30d7\u30fc (Ketoconazole Shampoo)
\n 13.5.4. \u30b5\u30ea\u30c1\u30eb\u9178\u30b7\u30e3\u30f3\u30d7\u30fc (Salicylic Acid Shampoo)
\n 13.6. \u30b9\u30d7\u30ec\u30fc (Spray)
\n14. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u6cbb\u7642\u30bf\u30a4\u30d7\u5225** (Seborrheic Dermatitis Treatment Market, by Treatment Type)
\n 14.1. \u7d4c\u53e3\u6cbb\u7642 (Oral Treatment)
\n 14.1.1. \u30d5\u30eb\u30b3\u30ca\u30be\u30fc\u30eb (Fluconazole)
\n 14.1.2. \u30a4\u30c8\u30e9\u30b3\u30ca\u30be\u30fc\u30eb (Itraconazole)
\n 14.1.3. \u30c6\u30eb\u30d3\u30ca\u30d5\u30a3\u30f3 (Terbinafine)
\n 14.2. \u5149\u7dda\u7642\u6cd5 (Phototherapy)
\n 14.2.1. PUVA (PUVA)
\n 14.2.2. UVA1 (UVA1)
\n 14.2.3. UVB (UVB)
\n 14.3. \u5916\u7528\u6cbb\u7642 (Topical Treatment)
\n 14.3.1. \u30b7\u30af\u30ed\u30d4\u30ed\u30c3\u30af\u30b9 (Ciclopirox)
\n 14.3.2. \u30b3\u30fc\u30eb\u30bf\u30fc\u30eb (Coal Tar)
\n 14.3.3. \u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb (Ketoconazole)
\n 14.3.4. \u30b5\u30ea\u30c1\u30eb\u9178 (Salicylic Acid)
\n15. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u85ac\u5264\u30af\u30e9\u30b9\u5225** (Seborrheic Dermatitis Treatment Market, by Drug Class)
\n 15.1. \u30a2\u30ea\u30eb\u30a2\u30df\u30f3\u7cfb (Allylamines)
\n 15.1.1. \u30ca\u30d5\u30c1\u30d5\u30a3\u30f3 (Naftifine)
\n 15.1.2. \u30c6\u30eb\u30d3\u30ca\u30d5\u30a3\u30f3 (Terbinafine)
\n 15.2. \u30a2\u30be\u30fc\u30eb\u7cfb (Azoles)
\n 15.2.1. \u30d5\u30eb\u30b3\u30ca\u30be\u30fc\u30eb (Fluconazole)
\n 15.2.2. \u30a4\u30c8\u30e9\u30b3\u30ca\u30be\u30fc\u30eb (Itraconazole)
\n 15.2.3. \u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb (Ketoconazole)
\n 15.3. \u786b\u5316\u7269 (Sulfides)
\n 15.3.1. \u786b\u5316\u30bb\u30ec\u30f3 (Selenium Sulfide)
\n16. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u88fd\u54c1\u30bf\u30a4\u30d7\u5225** (Seborrheic Dermatitis Treatment Market, by Product Type)
\n 16.1. \u5e02\u8ca9\u85ac (OTC) (Over-The-Counter)
\n 16.1.1. \u9ad8\u6fc3\u5ea6 (High Strength)
\n 16.1.2. \u4f4e\u6fc3\u5ea6 (Low Strength)
\n 16.1.3. \u6a19\u6e96\u6fc3\u5ea6 (Standard Strength)
\n 16.2. \u51e6\u65b9\u85ac (Prescription)
\n 16.2.1. \u9ad8\u6fc3\u5ea6 (High Strength)
\n 16.2.2. \u4f4e\u6fc3\u5ea6 (Low Strength)
\n 16.2.3. \u6a19\u6e96\u6fc3\u5ea6 (Standard Strength)
\n17. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225** (Seborrheic Dermatitis Treatment Market, by Distribution Channel)
\n 17.1. \u75c5\u9662\u85ac\u5c40 (Hospital Pharmacy)
\n 17.2. \u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af (Hospitals & Clinics)
\n 17.3. \u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40 (Online Pharmacy)
\n 17.4. \u5c0f\u58f2\u85ac\u5c40 (Retail Pharmacy)
\n18. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u5730\u57df\u5225** (Seborrheic Dermatitis Treatment Market, by Region)
\n 18.1. \u30a2\u30e1\u30ea\u30ab\u5927\u9678 (Americas)
\n 18.1.1. \u5317\u7c73 (North America)
\n 18.1.2. \u4e2d\u5357\u7c73 (Latin America)
\n 18.2. \u6b27\u5dde\u3001\u4e2d\u6771\u3001\u30a2\u30d5\u30ea\u30ab (Europe, Middle East & Africa)
\n 18.2.1. \u6b27\u5dde (Europe)
\n 18.2.2. \u4e2d\u6771 (Middle East)
\n 18.2.3. \u30a2\u30d5\u30ea\u30ab (Africa)
\n 18.3. \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b (Asia-Pacific)
\n19. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u30b0\u30eb\u30fc\u30d7\u5225** (Seborrheic Dermatitis Treatment Market, by Group)
\n 19.1. ASEAN (ASEAN)
\n 19.2. GCC (GCC)
\n 19.3. \u6b27\u5dde\u9023\u5408 (European Union)
\n 19.4. BRICS (BRICS)
\n 19.5. G7 (G7)
\n 19.6. NATO (NATO)
\n20. **\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u3001\u56fd\u5225** (Seborrheic Dermatitis Treatment Market, by Country)
\n 20.1. \u7c73\u56fd (United States)
\n 20.2. \u30ab\u30ca\u30c0 (Canada)
\n 20.3. \u30e1\u30ad\u30b7\u30b3 (Mexico)
\n 20.4. \u30d6\u30e9\u30b8\u30eb (Brazil)
\n 20.5. \u82f1\u56fd (United Kingdom)
\n 20.6. \u30c9\u30a4\u30c4 (Germany)
\n 20.7. \u30d5\u30e9\u30f3\u30b9 (France)
\n 20.8. \u30ed\u30b7\u30a2 (Russia)
\n 20.9. \u30a4\u30bf\u30ea\u30a2 (Italy)
\n 20.10. \u30b9\u30da\u30a4\u30f3 (Spain)
\n 20.11. \u4e2d\u56fd (China)
\n 20.12. \u30a4\u30f3\u30c9 (India)
\n 20.13. \u65e5\u672c (Japan)
\n 20.14. \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2 (Australia)
\n 20.15. \u97d3\u56fd (South Korea)
\n21. **\u7af6\u5408\u60c5\u52e2** (Competitive Landscape)
\n 21.1. \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u30012024\u5e74 (Market Share Analysis, 2024)
\n 21.2. FPNV\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u30012024\u5e74 (FPNV Positioning Matrix, 2024)
\n 21.3. \u7af6\u5408\u5206\u6790 (Competitive Analysis)
\n 21.3.1. \u30d7\u30ed\u30af\u30bf\u30fc\u30fb\u30a2\u30f3\u30c9\u30fb\u30ae\u30e3\u30f3\u30d6\u30eb\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc (The Procter & Gamble Company)
\n 21.3.2. \u30b8\u30e7\u30f3\u30bd\u30f3\u30fb\u30a8\u30f3\u30c9\u30fb\u30b8\u30e7\u30f3\u30bd\u30f3\u30fb\u30b5\u30fc\u30d3\u30b7\u30ba\u30fb\u30a4\u30f3\u30af (Johnson & Johnson Services, Inc.)
\n 21.3.3. \u30ed\u30ec\u30a2\u30ebS.A. (L’Or\u00e9al S.A.)
\n 21.3.4. \u30b5\u30ce\u30d5\u30a3S.A. (Sanofi S.A.)
\n 21.3.5. \u30d0\u30a4\u30a8\u30ebAG (Bayer AG)
\n 21.3.6. \u30ac\u30eb\u30c7\u30eb\u30deS.A. (Galderma S.A.)
\n 21.3.7. \u30d0\u30a6\u30b7\u30e5\u30fb\u30d8\u30eb\u30b9\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc\u30ba\u30fb\u30a4\u30f3\u30af (Bausch Health Companies Inc.)
\n 21.3.8. \u30d4\u30a8\u30fc\u30eb\u30fb\u30d5\u30a1\u30fc\u30d6\u30ebS.A. (Pierre Fabre S.A.)
\n 21.3.9. \u30f4\u30a3\u30a2\u30c8\u30ea\u30b9\u30fb\u30a4\u30f3\u30af (Viatris Inc.)
\n 21.3.10. \u30b0\u30ec\u30f3\u30de\u30fc\u30af\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u30fb\u30ea\u30df\u30c6\u30c3\u30c9 (Glenmark Pharmaceuticals Limited)
\n22. **\u56f3\u306e\u30ea\u30b9\u30c8 [\u5408\u8a08: 30]** (List of Figures [Total: 30])
\n23. **\u8868\u306e\u30ea\u30b9\u30c8 [\u5408\u8a08: 1293]** (List of Tables [Total: 1293])<\/p>\n

………… (\u4ee5\u4e0b\u7701\u7565)<\/p>\n","protected":false},"excerpt":{"rendered":"

## \u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\uff1a\u8a73\u7d30\u5206\u6790\u3068\u5c06\u6765\u5c55\u671b<\/p>\n

### \u5e02\u5834\u6982\u8981<\/p>\n

\u8102\u6f0f\u6027\u76ae\u819a\u708e\u306f\u3001\u76ae\u8102\u817a\u304c\u8c4a\u5bcc\u306a\u90e8\u4f4d\u306b\u6162\u6027\u7684\u306b\u518d\u767a\u3059\u308b\u708e\u75c7\u3092\u7279\u5fb4\u3068\u3059\u308b\u3001\u81e8\u5e8a\u7684\u304a\u3088\u3073\u5546\u696d\u7684\u306b\u91cd\u8981\u306a\u8ab2\u984c\u3092\u63d0\u793a\u3057\u3066\u3044\u307e\u3059\u3002JAMA Dermatology\u306b\u63b2\u8f09\u3055\u308c\u305f\u5927\u898f\u6a21\u306a\u30e1\u30bf\u30a2\u30ca\u30ea\u30b7\u30b9\u306b\u3088\u308b\u3068\u3001\u3053\u306e\u75be\u60a3\u306e\u4e16\u754c\u7684\u306a\u6709\u75c5\u7387\u306f\u7d044.38%\u3067\u3042\u308a\u3001\u6210\u4eba\u4eba\u53e3\u304c\u6700\u3082\u9ad8\u3044\u7f79\u60a3\u7387\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u7c73\u56fd\u3067\u306f\u3001\u6700\u8fd1\u306e\u75ab\u5b66\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u6210\u4eba\u306b\u304a\u3051\u308b\u6709\u75c5\u7387\u306f5.86%\u3068\u308f\u305a\u304b\u306b\u9ad8\u304f\u3001\u6a19\u7684\u578b\u6cbb\u7642\u4ecb\u5165\u306e\u5fc5\u8981\u6027\u304c\u5f37\u8abf\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u75be\u60a3\u306f\u3001\u4e3b\u306b\u982d\u76ae\u3001\u9854\u9762\u3001\u4e0a\u90e8\u4f53\u5e79\u306b\u7d05\u6591\u6027\u3067\u8102\u304e\u3063\u305f\u9c57\u5c51\u3068\u3057\u3066\u73fe\u308c\u3001\u3057\u3070\u3057\u3070\u5f37\u3044\u304b\u3086\u307f\u3084\u5fc3\u7406\u793e\u4f1a\u7684\u82e6\u75db\u3092\u4f34\u3044\u307e\u3059\u3002<\/p>\n

\u539f\u56e0\u3068\u3057\u3066\u306f\u3001\u30de\u30e9\u30bb\u30c1\u30a2\u9175\u6bcd\u306e\u5897\u6b96\u3001\u907a\u4f1d\u7684\u7d20\u56e0\u3001\u30db\u30eb\u30e2\u30f3\u306e\u5f71\u97ff\u3001\u5bd2\u51b7\u6c17\u5019\u3084\u9ad8\u6e7f\u5ea6\u306a\u3069\u306e\u74b0\u5883\u30b9\u30c8\u30ec\u30b9\u8981\u56e0\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u75be\u60a3\u7ba1\u7406\u306f\u3001\u30bb\u30eb\u30d5\u30b1\u30a2\u3001\u5e02\u8ca9\u306e\u30d5\u30b1\u9632\u6b62\u30b7\u30e3\u30f3\u30d7\u30fc\u3001\u51e6\u65b9\u7b8b\u5f37\u5ea6\u306e\u6297\u771f\u83cc\u85ac\u3001\u305d\u3057\u3066\u65b0\u8208\u306e\u6297\u708e\u75c7\u5264\u306a\u3069\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u6cbb\u7642\u306e\u72b6\u6cc1\u306f\u3001\u5f93\u6765\u306e\u6297\u771f\u83cc\u85ac\u3084\u89d2\u8cea\u6eb6\u89e3\u85ac\u3092\u8d85\u3048\u3066\u62e1\u5927\u3057\u3066\u304a\u308a\u3001\u696d\u754c\u306e\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u306f\u30d5\u30a9\u30fc\u30e0\u3084\u5c40\u6240\u88fd\u5264\u3092\u9032\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u5c02\u9580\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u3001\u6a19\u7684\u578b\u6297\u708e\u75c7\u5264\u3084\u514d\u75ab\u8abf\u7bc0\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u3001\u4e7e\u766c\u3068\u8102\u6f0f\u6027\u76ae\u819a\u708e\u306e\u4e21\u65b9\u306b\u5bfe\u5fdc\u3059\u308b\u753b\u671f\u7684\u306a\u30d5\u30a9\u30fc\u30e0\u88fd\u5264\u306f\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696dArcutis Biotherapeutics\u3092\u6ce8\u76ee\u3055\u305b\u3001\u7cbe\u5bc6\u76ae\u819a\u79d1\u5b66\u3078\u306e\u30bb\u30af\u30bf\u30fc\u5168\u4f53\u306e\u79fb\u884c\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u5e02\u5834\u306f\u3001\u88fd\u5264\uff08\u30af\u30ea\u30fc\u30e0\u3001\u30d5\u30a9\u30fc\u30e0\u3001\u30b8\u30a7\u30eb\u306a\u3069\uff09\u3001\u6cbb\u7642\u30bf\u30a4\u30d7\uff08\u7d4c\u53e3\u6cbb\u7642\u3001\u5149\u7dda\u7642\u6cd5\u3001\u5c40\u6240\u6cbb\u7642\u306a\u3069\uff09\u3001\u85ac\u5264\u30af\u30e9\u30b9\u3001\u88fd\u54c1\u30bf\u30a4\u30d7\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u3068\u3044\u3063\u305f\u660e\u78ba\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u985e\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u304c\u72ec\u81ea\u306e\u6210\u9577\u8981\u56e0\u3068\u9769\u65b0\u306e\u6a5f\u4f1a\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

### \u4fc3\u9032\u8981\u56e0<\/p>\n

**1. \u6280\u8853\u7684\u304a\u3088\u3073\u898f\u5236\u4e0a\u306e\u5909\u9769**
\n\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u30bb\u30af\u30bf\u30fc\u306f\u3001\u65b0\u3057\u3044\u79d1\u5b66\u3068\u9032\u5316\u3059\u308b\u898f\u5236\u306e\u67a0\u7d44\u307f\u306b\u3088\u3063\u3066\u63a8\u9032\u3055\u308c\u308b\u5909\u9769\u671f\u3092\u8fce\u3048\u3066\u3044\u307e\u3059\u3002\u6700\u8fd1\u306e\u81e8\u5e8a\u30c7\u30fc\u30bf\u306f\u3001\u3053\u306e\u75be\u60a3\u306e\u75c5\u614b\u751f\u7406\u5b66\u304c\u4e3b\u306b\u708e\u75c7\u6027\u3067\u3042\u308b\u3068\u518d\u5b9a\u7fa9\u3057\u3001\u8abf\u7bc0\u4e0d\u5168\u306e\u514d\u75ab\u7d4c\u8def\u3092\u76f4\u63a5\u6a19\u7684\u3068\u3059\u308b\u65b0\u3057\u3044\u5c40\u6240\u6297\u708e\u75c7\u5264\u306e\u958b\u767a\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u7b2c27\u56de\u5e74\u6b21\u51ac\u5b63\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3067\u767a\u8868\u3055\u308c\u305f\u8a3c\u62e0\u306f\u30012023\u5e74\u5f8c\u534a\u306b\u627f\u8a8d\u3055\u308c\u305f0.3%\u30ed\u30d5\u30eb\u30df\u30e9\u30b9\u30c8\u30d5\u30a9\u30fc\u30e0\u306a\u3069\u306e\u30db\u30b9\u30db\u30b8\u30a8\u30b9\u30c6\u30e9\u30fc\u30bc-4\uff08PDE4\uff09\u963b\u5bb3\u5264\u306e\u512a\u308c\u305f\u6709\u52b9\u6027\u3092\u5f37\u8abf\u3057\u3066\u304a\u308a\u3001\u4e3b\u8981\u306a\u8a66\u9a13\u30678\u9031\u9593\u307e\u3067\u306b\u7d0480%\u306e\u30af\u30ea\u30a2\u30e9\u30f3\u30b9\u7387\u3092\u9054\u6210\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u4e00\u65b9\u3001JAK\u963b\u5bb3\u5264\u3084\u65b0\u898f\u30d7\u30ed\u30c6\u30a4\u30f3\u5206\u89e3\u5264\u306e\u767b\u5834\u306f\u3001\u6cbb\u7642\u9078\u629e\u80a2\u3092\u3055\u3089\u306b\u62e1\u5927\u3059\u308b\u614b\u52e2\u3092\u6574\u3048\u3066\u3044\u307e\u3059\u3002\u7d4c\u53e3STAT6\u5206\u89e3\u5264\u306e\u6700\u8fd1\u306e\u7b2c1\u76f8\u8a66\u9a13\u3067\u306f\u3001\u708e\u75c7\u6027\u30e1\u30c7\u30a3\u30a8\u30fc\u30bf\u30fc\u306b\u304a\u3051\u308b\u6709\u671b\u306a\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u6e1b\u5c11\u304c\u793a\u3055\u308c\u3001\u65e2\u5b58\u306e\u6ce8\u5c04\u5264\u306b\u5339\u6575\u3059\u308b\u5b89\u5168\u3067\u52b9\u679c\u7684\u306a\u7d4c\u53e3\u6cbb\u7642\u30d1\u30e9\u30c0\u30a4\u30e0\u306e\u53ef\u80fd\u6027\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002\u5c40\u6240\u30eb\u30ad\u30bd\u30ea\u30c1\u30cb\u30d6\u3082\u8abf\u67fb\u4e2d\u3067\u3001\u7b2c2\u76f8\u8a66\u9a13\u3067\u306f\u5206\u5b50\u514d\u75ab\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u7279\u5fb4\u3065\u3051\u3089\u308c\u3001\u8fc5\u901f\u306a\u75c7\u72b6\u7de9\u548c\u304c\u78ba\u8a8d\u3055\u308c\u3066\u304a\u308a\u3001\u7cbe\u5bc6\u6a19\u7684\u7642\u6cd5\u3078\u306e\u52e2\u3044\u3092\u88cf\u4ed8\u3051\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u4e26\u884c\u3057\u3066\u3001\u898f\u5236\u5f53\u5c40\u306f\u533b\u85ac\u54c1\u8f38\u5165\u306b\u5bfe\u3059\u308b\u76e3\u8996\u3092\u5f37\u5316\u3057\u3066\u304a\u308a\u3001\u88fd\u9020\u696d\u8005\u306f\u533b\u85ac\u54c1\u958b\u767a\u3092\u52a0\u901f\u3057\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u3068\u306e\u7dca\u5bc6\u306a\u5354\u529b\u3092\u4fc3\u9032\u3059\u308b\u3088\u3046\u4fc3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u9060\u9694\u76ae\u819a\u79d1\u304a\u3088\u3073\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u9060\u9694\u60a3\u8005\u7ba1\u7406\u3001\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u6cbb\u7642\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u60a3\u8005\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u53ef\u80fd\u306b\u3059\u308b\u305f\u3081\u306b\u727d\u5f15\u529b\u3092\u5897\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u9032\u5c55\u306f\u3001\u5e83\u7bc4\u56f2\u30b9\u30da\u30af\u30c8\u30eb\u6297\u771f\u83cc\u85ac\u304b\u3089\u3001\u30c7\u30b8\u30bf\u30eb\u30c4\u30fc\u30eb\u3068\u5408\u7406\u5316\u3055\u308c\u305f\u898f\u5236\u7d4c\u8def\u306b\u3088\u3063\u3066\u30b5\u30dd\u30fc\u30c8\u3055\u308c\u308b\u6d17\u7df4\u3055\u308c\u305f\u30e1\u30ab\u30cb\u30ba\u30e0\u30d9\u30fc\u30b9\u306e\u4ecb\u5165\u3078\u306e\u6839\u672c\u7684\u306a\u79fb\u884c\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

**2. 2025\u5e74\u7c73\u56fd\u95a2\u7a0e\u653f\u7b56\u306e\u5f71\u97ff**
\n2025\u5e74\u306b\u7c73\u56fd\u3067\u65bd\u884c\u3055\u308c\u305f\u30bb\u30af\u30b7\u30e7\u30f3232\u304a\u3088\u3073\u95a2\u9023\u8cbf\u6613\u653f\u7b56\u306b\u57fa\u3065\u304f\u4e00\u9023\u306e\u95a2\u7a0e\u306f\u3001\u533b\u85ac\u54c1\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3068\u30b3\u30b9\u30c8\u69cb\u9020\u306b\u91cd\u5927\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u4e2d\u56fd\u3068\u30a4\u30f3\u30c9\u304b\u3089\u8abf\u9054\u3055\u308c\u308b\u539f\u85ac\uff08API\uff09\u3092\u542b\u3080\u4e00\u90e8\u306e\u533b\u85ac\u54c1\u8f38\u5165\u306b\u5bfe\u3059\u308b25%\u306e\u95a2\u7a0e\u306f\u3001\u533b\u85ac\u54c1\u751f\u7523\u306b\u5373\u5ea7\u306b\u30a4\u30f3\u30d5\u30ec\u52b9\u679c\u3092\u3082\u305f\u3089\u3057\u3001\u696d\u754c\u5206\u6790\u3067\u306f\u3001\u6d88\u8cbb\u8005\u306b\u5b8c\u5168\u306b\u8ee2\u5ac1\u3055\u308c\u305f\u5834\u5408\u3001\u30b3\u30b9\u30c8\u304c\u6700\u592712.9%\u5897\u52a0\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u30014\u67085\u65e5\u4ee5\u964d\u306b\u3059\u3079\u3066\u306e\u8f38\u5165\u306b\u9069\u7528\u3055\u308c\u305f\u4e16\u754c\u7684\u306a10%\u306e\u95a2\u7a0e\u306f\u3001API\u3001\u533b\u7642\u6a5f\u5668\u3001\u8a3a\u65ad\u30c4\u30fc\u30eb\u3092\u542b\u3080\u91cd\u8981\u306a\u30d8\u30eb\u30b9\u30b1\u30a2\u90e8\u54c1\u306e\u30b3\u30b9\u30c8\u3092\u3055\u3089\u306b\u4e0a\u6607\u3055\u305b\u307e\u3057\u305f\u3002<\/p>\n

\u307e\u305f\u3001API\u306b\u306f20%\u304b\u308925%\u3001\u533b\u85ac\u54c1\u6a5f\u68b0\u8a2d\u5099\u306b\u306f\u6700\u592725%\u306e\u7279\u5b9a\u306e\u8ab2\u5fb4\u91d1\u304c\u8ab2\u3055\u308c\u3001\u88fd\u9020\u696d\u8005\u306f\u8abf\u9054\u6226\u7565\u306e\u898b\u76f4\u3057\u3001\u56fd\u5185\u751f\u7523\u6295\u8cc7\u306e\u52a0\u901f\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u5951\u7d04\u306e\u518d\u4ea4\u6e09\u3092\u4f59\u5100\u306a\u304f\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u4f01\u696d\u306f\u77ed\u671f\u7684\u306a\u30b3\u30b9\u30c8\u6025\u5897\u3092\u7de9\u548c\u3059\u308b\u305f\u3081\u306b\u9078\u629e\u7684\u306a\u95a2\u7a0e\u514d\u9664\u3068\u6bb5\u968e\u7684\u306a\u5b9f\u65bd\u3092\u6c42\u3081\u3066\u3044\u307e\u3059\u304c\u3001\u77ed\u671f\u7684\u306a\u5f71\u97ff\u306f\u30de\u30fc\u30b8\u30f3\u74b0\u5883\u306e\u5727\u8feb\u3068\u3001\u652f\u6255\u8005\u304a\u3088\u3073\u60a3\u8005\u9593\u306e\u4fa1\u683c\u611f\u5ea6\u306e\u9ad8\u307e\u308a\u3068\u3057\u3066\u6b8b\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u653f\u7b56\u8ee2\u63db\u306f\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u591a\u69d8\u5316\u3092\u4fc3\u9032\u3057\u3001\u7c73\u56fd\u3092\u62e0\u70b9\u3068\u3059\u308b\u88fd\u9020\u65bd\u8a2d\u3078\u306e\u8cc7\u672c\u914d\u5206\u3092\u5897\u52a0\u3055\u305b\u3001\u904e\u5270\u306a\u95a2\u7a0e\u8ca0\u62c5\u3092\u8efd\u6e1b\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u305f\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u4fc3\u3057\u3066\u3044\u307e\u3059\u3002\u9577\u671f\u7684\u306a\u76ee\u6a19\u306b\u306f\u91cd\u8981\u306a\u751f\u7523\u80fd\u529b\u306e\u56fd\u5185\u56de\u5e30\u304c\u542b\u307e\u308c\u307e\u3059\u304c\u3001\u30bb\u30af\u30bf\u30fc\u306f\u80fd\u529b\u62e1\u5927\u306b\u304b\u306a\u308a\u306e\u30ea\u30fc\u30c9\u30bf\u30a4\u30e0\u3092\u8981\u3059\u308b\u305f\u3081\u3001\u73fe\u5728\u306e\u898f\u5236\u74b0\u5883\u4e0b\u3067\u306e\u6a5f\u654f\u306a\u30ea\u30b9\u30af\u7ba1\u7406\u3068\u9069\u5fdc\u7684\u306a\u4fa1\u683c\u6226\u7565\u306e\u5fc5\u8981\u6027\u304c\u5f37\u8abf\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

**3. \u30bb\u30b0\u30e1\u30f3\u30c8\u56fa\u6709\u306e\u6210\u9577\u3068\u9769\u65b0\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9**
\n\u88fd\u5264\u3001\u6cbb\u7642\u30bf\u30a4\u30d7\u3001\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u3001\u85ac\u5264\u30af\u30e9\u30b9\u3001\u88fd\u54c1\u30bf\u30a4\u30d7\u306b\u308f\u305f\u308b\u30bb\u30b0\u30e1\u30f3\u30c8\u5206\u6790\u306f\u3001\u5e02\u5834\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3092\u727d\u5f15\u3059\u308b\u5fae\u5999\u306a\u30c8\u30ec\u30f3\u30c9\u3092\u660e\u3089\u304b\u306b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

* **\u88fd\u5264\u30bb\u30b0\u30e1\u30f3\u30c8**\u3067\u306f\u3001\u30b7\u30af\u30ed\u30d4\u30ed\u30c3\u30af\u30b9\u3001\u30b3\u30fc\u30eb\u30bf\u30fc\u30eb\u3001\u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb\u3092\u542b\u3080\u5c40\u6240\u30af\u30ea\u30fc\u30e0\u304c\u60a3\u8005\u306e\u99b4\u67d3\u307f\u3084\u3059\u3055\u3068\u30a2\u30c9\u30d2\u30a2\u30e9\u30f3\u30b9\u3092\u727d\u5f15\u3059\u308b\u4e00\u65b9\u3067\u3001\u9769\u65b0\u7684\u306a\u30d5\u30a9\u30fc\u30e0\u3084\u30b9\u30d7\u30ec\u30fc\u306e\u5f62\u614b\u304c\u982d\u76ae\u3084\u8eab\u4f53\u3078\u306e\u6a19\u7684\u9069\u7528\u3068\u3057\u3066\u767b\u5834\u3057\u3066\u3044\u307e\u3059\u3002\u30b7\u30af\u30ed\u30d4\u30ed\u30c3\u30af\u30b9\u3001\u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb\u3001\u30b5\u30ea\u30c1\u30eb\u9178\u3092\u7279\u5fb4\u3068\u3059\u308b\u30b8\u30a7\u30eb\u3084\u30ed\u30fc\u30b7\u30e7\u30f3\u306e\u5f62\u614b\u306f\u3001\u30c6\u30af\u30b9\u30c1\u30e3\u30fc\u3068\u5438\u53ce\u7387\u306b\u5bfe\u3059\u308b\u60a3\u8005\u306e\u597d\u307f\u306b\u5bfe\u5fdc\u3057\u3066\u304a\u308a\u3001\u85ac\u7528\u30b7\u30e3\u30f3\u30d7\u30fc\u306e\u666e\u53ca\u306f\u65e5\u5e38\u7684\u306a\u7ba1\u7406\u30ec\u30b8\u30e1\u30f3\u306e\u4e2d\u5fc3\u3067\u3042\u308a\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002
\n* **\u6cbb\u7642\u30bf\u30a4\u30d7\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3**\u306f\u4e09\u90e8\u69cb\u9020\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002\u30d5\u30eb\u30b3\u30ca\u30be\u30fc\u30eb\u3001\u30a4\u30c8\u30e9\u30b3\u30ca\u30be\u30fc\u30eb\u3001\u30c6\u30eb\u30d3\u30ca\u30d5\u30a3\u30f3\u3092\u542b\u3080\u7d4c\u53e3\u30ec\u30b8\u30e1\u30f3\u306f\u3001\u96e3\u6cbb\u6027\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u5168\u8eab\u5236\u5fa1\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002PUVA\u3001UVA1\u3001UVB\u306a\u3069\u306e\u5149\u7dda\u7642\u6cd5\u306f\u3001\u5e83\u7bc4\u56f2\u306b\u308f\u305f\u308b\u75c5\u5909\u306b\u5bfe\u3059\u308b\u88dc\u52a9\u7684\u306a\u9078\u629e\u80a2\u3068\u3057\u3066\u6a5f\u80fd\u3057\u307e\u3059\u3002\u305d\u3057\u3066\u3001\u30b7\u30af\u30ed\u30d4\u30ed\u30c3\u30af\u30b9\u3001\u30b3\u30fc\u30eb\u30bf\u30fc\u30eb\u3001\u30b1\u30c8\u30b3\u30ca\u30be\u30fc\u30eb\u3001\u30b5\u30ea\u30c1\u30eb\u9178\u306a\u3069\u306e\u6709\u52b9\u6210\u5206\u3092\u542b\u3080\u5c40\u6240\u7642\u6cd5\u304c\u3001\u81e8\u5e8a\u5229\u7528\u306e\u5927\u90e8\u5206\u3092\u5360\u3081\u308b\u57fa\u76e4\u3067\u3042\u308a\u7d9a\u3051\u3066\u3044\u307e\u3059\u3002
\n* **\u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5206\u6790**\u306f\u3001\u30aa\u30e0\u30cb\u30c1\u30e3\u30cd\u30eb\u30a2\u30af\u30bb\u30b7\u30d3\u30ea\u30c6\u30a3\u306e\u9032\u5316\u3059\u308b\u91cd\u8981\u6027\u3092\u78ba\u8a8d\u3057\u3066\u304a\u308a\u3001\u75c5\u9662\u85ac\u5c40\u3084\u8a3a\u7642\u6240\u304c\u3001\u5f93\u6765\u306e\u5c0f\u58f2\u5e97\u3092\u88dc\u5b8c\u3059\u308b\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306e\u5b58\u5728\u611f\u306e\u5897\u5927\u3068\u5171\u5b58\u3057\u3066\u3044\u307e\u3059\u3002
\n* **\u85ac\u5264\u30af\u30e9\u30b9\u306e\u5dee\u5225\u5316**\u306f\u3001\u30a2\u30ea\u30eb\u30a2\u30df\u30f3\u7cfb\u304a\u3088\u3073\u30a2\u30be\u30fc\u30eb\u7cfb\u306e\u6226\u7565\u7684\u4fa1\u5024\u3092\u5f37\u8abf\u3057\u3066\u304a\u308a\u3001\u30ca\u30d5\u30c1\u30d5\u30a3\u30f3\u3001\u30c6\u30eb\u30d3\u30ca\u30d5\u30a3\u30f3\u3001\u304a\u3088\u3073\u69d8\u3005\u306a\u30a2\u30be\u30fc\u30eb\u7cfb\u85ac\u5264\u304c\u6297\u771f\u83cc\u52b9\u679c\u306b\u304a\u3044\u3066\u81e8\u5e8a\u7684\u9078\u597d\u3092\u5360\u3081\u308b\u4e00\u65b9\u3067\u3001\u786b\u5316\u30bb\u30ec\u30f3\u306f\u786b\u9ec4\u30d9\u30fc\u30b9\u306e\u6cbb\u7642\u6cd5\u306e\u4e2d\u3067\u72ec\u81ea\u306e\u30cb\u30c3\u30c1\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002
\n* \u6700\u5f8c\u306b\u3001**\u88fd\u54c1\u30bf\u30a4\u30d7\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3**\u306f\u3001\u5e02\u8ca9\u85ac\u3068\u51e6\u65b9\u85ac\u306e\u63d0\u4f9b\u306e\u9593\u3067\u3001\u3055\u3089\u306b\u5f37\u5ea6\u30ec\u30d9\u30eb\uff08\u9ad8\u3001\u4f4e\u3001\u6a19\u6e96\uff09\u306b\u3088\u3063\u3066\u5c64\u5225\u5316\u3055\u308c\u3066\u304a\u308a\u3001\u6bb5\u968e\u7684\u306a\u4fa1\u683c\u8a2d\u5b9a\u30e2\u30c7\u30eb\u3068\u6d88\u8cbb\u8005\u306e\u30ea\u30b9\u30af\u8a31\u5bb9\u5ea6\u3092\u53cd\u6620\u3057\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u3068\u60a3\u8005\u6559\u80b2\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306e\u5fc5\u8981\u6027\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

**4. \u5730\u57df\u5e02\u5834\u306e\u52d5\u5411\u3068\u6210\u9577\u6a5f\u4f1a**
\n\u5730\u57df\u5e02\u5834\u306e\u52d5\u5411\u306f\u3001\u898f\u5236\u69cb\u9020\u3001\u533b\u7642\u30a4\u30f3\u30d5\u30e9\u3001\u6d88\u8cbb\u8005\u306e\u55dc\u597d\u306b\u3088\u3063\u3066\u9855\u8457\u306a\u683c\u5dee\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

* **\u30a2\u30e1\u30ea\u30ab\u5927\u9678**\u3067\u306f\u3001\u9ad8\u3044\u533b\u7642\u8cbb\u652f\u51fa\u3068\u5305\u62ec\u7684\u306a\u511f\u9084\u67a0\u7d44\u307f\u304c\u3001\u65b0\u898f\u306e\u5c40\u6240\u7642\u6cd5\u304a\u3088\u3073\u5168\u8eab\u7642\u6cd5\u306e\u8fc5\u901f\u306a\u63a1\u7528\u3092\u652f\u3048\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u7c73\u56fd\u306f\u3001\u7cbe\u5bc6\u76ae\u819a\u79d1\u5b66\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u5805\u8abf\u306a\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3068\u3001\u5c02\u9580\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u304b\u3089\u306e\u6301\u7d9a\u7684\u306a\u95a2\u5fc3\u3092\u793a\u3057\u3066\u3044\u308b\u4e00\u65b9\u3067\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u5e02\u5834\u306f\u3001\u8cbb\u7528\u5bfe\u52b9\u679c\u306e\u9ad8\u3044\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3068\u9060\u9694\u85ac\u5c40\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u901a\u3058\u305f\u30a2\u30af\u30bb\u30b9\u5f37\u5316\u3092\u512a\u5148\u3057\u3066\u3044\u307e\u3059\u3002
\n* **\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u4e2d\u6771\u3001\u30a2\u30d5\u30ea\u30ab\uff08EMEA\uff09**\u3067\u306f\u3001\u898f\u5236\u306e\u591a\u69d8\u6027\u304c\u8ab2\u984c\u3068\u6a5f\u4f1a\u306e\u4e21\u65b9\u3092\u3082\u305f\u3089\u3057\u3066\u3044\u307e\u3059\u3002\u897f\u30e8\u30fc\u30ed\u30c3\u30d1\u306e\u898f\u5236\u6a5f\u95a2\u306f\u3001\u5148\u9032\u7684\u306a\u751f\u7269\u5b66\u7684\u88fd\u5264\u3084\u4f4e\u5206\u5b50\u9769\u65b0\u306e\u53c2\u5165\u3092\u4fc3\u9032\u3059\u308b\u4e00\u65b9\u3067\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u65b0\u8208\u5e02\u5834\u306f\u3001\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u3092\u6e80\u305f\u3059\u305f\u3081\u306e\u624b\u9803\u3067\u30b9\u30b1\u30fc\u30e9\u30d6\u30eb\u306a\u6cbb\u7642\u6cd5\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002\u5730\u5143\u306e\u88fd\u9020\u696d\u8005\u306f\u3001\u78ba\u7acb\u3055\u308c\u305f\u6d41\u901a\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u6d3b\u7528\u3057\u3066\u3001\u30d6\u30e9\u30f3\u30c9\u88fd\u5264\u3068\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u88fd\u5264\u306e\u4e21\u65b9\u3092\u63d0\u4f9b\u3057\u3001\u5730\u57df\u5168\u4f53\u3067\u591a\u69d8\u306a\u511f\u9084\u30e2\u30c7\u30eb\u3092\u30ca\u30d3\u30b2\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002
\n* **\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5e02\u5834**\u306f\u3001\u6025\u901f\u306b\u62e1\u5927\u3059\u308b\u533b\u7642\u8cbb\u652f\u51fa\u3001\u8102\u6f0f\u6027\u76ae\u819a\u708e\u306e\u6709\u75c5\u7387\u306e\u4e0a\u6607\u3001\u304a\u3088\u3073\u90fd\u5e02\u5316\u306e\u9032\u5c55\u3092\u7279\u5fb4\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u3001\u30a4\u30f3\u30c9\u3001\u65e5\u672c\u306a\u3069\u306e\u4e3b\u8981\u5e02\u5834\u3067\u306f\u3001\u6d88\u8cbb\u8005\u306e\u610f\u8b58\u304c\u9ad8\u307e\u308a\u3001\u30d7\u30ec\u30df\u30a2\u30e0\u30b9\u30ad\u30f3\u30b1\u30a2\u304a\u3088\u3073\u6cbb\u7642\u88fd\u54c1\u3078\u306e\u6295\u8cc7\u610f\u6b32\u304c\u5897\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u76ae\u819a\u79d1\u30b5\u30fc\u30d3\u30b9\u3092\u5f37\u5316\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u305f\u5b98\u6c11\u306e\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u304c\u3001\u4f1d\u7d71\u7684\u304a\u3088\u3073\u65b0\u898f\u306e\u6cbb\u7642\u6cd5\u306e\u4e21\u65b9\u306b\u5bfe\u3059\u308b\u9700\u8981\u3092\u4fc3\u9032\u3057\u3066\u304a\u308a\u3001\u3053\u306e\u5730\u57df\u3092\u91cd\u8981\u306a\u6210\u9577\u30a8\u30f3\u30b8\u30f3\u3068\u3057\u3066\u4f4d\u7f6e\u3065\u3051\u3066\u3044\u307e\u3059\u3002<\/p>\n

### \u5e02\u5834\u306e\u65b9\u5411\u6027\uff08\u5c55\u671b\uff09<\/p>\n

**1. \u7af6\u4e89\u74b0\u5883\u3068\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa**
\n\u7af6\u4e89\u74b0\u5883\u306f\u3001\u78ba\u7acb\u3055\u308c\u305f\u88fd\u85ac\u5927\u624b\u3068\u6a19\u7684\u578b\u5c02\u9580\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3092\u7279\u5fb4\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u30b3\u30f3\u30b7\u30e5\u30fc\u30de\u30fc\u30b9\u30c6\u30fc\u30d7\u30eb\u306f\u3001Head & Shoulders\u3001Dove\u3001Nizoral\u306a\u3069\u306e\u8c61\u5fb4\u7684\u306a\u30d6\u30e9\u30f3\u30c9\u3092\u901a\u3058\u3066\u5e02\u8ca9\u85ac\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u652f\u914d\u3057\u3001\u5f37\u529b\u306a\u30d6\u30e9\u30f3\u30c9\u30ed\u30a4\u30e4\u30eb\u30c6\u30a3\u3068\u68da\u3067\u306e\u5b58\u5728\u611f\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002\u51e6\u65b9\u85ac\u5206\u91ce\u3067\u306f\u3001Arcutis Biotherapeutics\u306e\u3088\u3046\u306a\u5c02\u9580\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u304c\u3001\u30e1\u30ab\u30cb\u30ba\u30e0\u30d9\u30fc\u30b9\u306e\u30d5\u30a9\u30fc\u30e0\u88fd\u5264\u3084PDE4\u963b\u5bb3\u5264\u3067\u727d\u5f15\u529b\u3092\u7372\u5f97\u3057\u3066\u304a\u308a\u3001\u7cbe\u5bc6\u6a19\u7684\u7642\u6cd5\u3078\u306e\u79fb\u884c\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3001Galderma\u306e\u591a\u69d8\u306a\u76ae\u819a\u79d1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\uff08\u6cbb\u7642\u7528\u5c40\u6240\u85ac\u304b\u3089\u6ce8\u5c04\u7528\u7f8e\u5bb9\u88fd\u54c1\u307e\u3067\uff09\u306f\u30012\u6841\u306e\u7d14\u58f2\u4e0a\u9ad8\u6210\u9577\u3092\u727d\u5f15\u3057\u3001\u4e3b\u8981\u5e02\u5834\u306b\u304a\u3051\u308b\u5805\u8abf\u306a\u4e8b\u696d\u9042\u884c\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u5927\u624b\u88fd\u85ac\u4f01\u696d\u306f\u3001\u5e83\u7bc4\u306a\u7814\u7a76\u958b\u767a\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u6d41\u901a\u80fd\u529b\u3001\u7d71\u5408\u3055\u308c\u305f\u88fd\u9020\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u901a\u3058\u3066\u305d\u306e\u5730\u4f4d\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002Johnson & Johnson\u3001Bayer\u3001GSK\u306a\u3069\u306e\u4f01\u696d\u306f\u3001\u6b21\u4e16\u4ee3\u88fd\u5264\u3068\u30c7\u30b8\u30bf\u30eb\u60a3\u8005\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u306b\u6295\u8cc7\u3092\u7d9a\u3051\u3066\u304a\u308a\u3001AbbVie\u306f\u514d\u75ab\u8abf\u7bc0\u5264\u306e\u5c02\u9580\u77e5\u8b58\u3092\u6d3b\u7528\u3057\u3066\u91cd\u5ea6\u304a\u3088\u3073\u6cbb\u7642\u62b5\u6297\u6027\u306e\u75c7\u4f8b\u306b\u5bfe\u51e6\u3057\u3066\u3044\u307e\u3059\u3002\u65b0\u8208\u4f01\u696d\u306f\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u9001\u9054\u6280\u8853\u3068\u65b0\u898f\u306e\u514d\u75ab\u8abf\u7bc0\u30e2\u30c0\u30ea\u30c6\u30a3\u306b\u7126\u70b9\u3092\u5f53\u3066\u3001\u7af6\u4e89\u3092\u6fc0\u5316\u3055\u305b\u3001\u6cbb\u7642\u30b9\u30da\u30af\u30c8\u30eb\u5168\u4f53\u3067\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n

**2. \u696d\u754c\u30ea\u30fc\u30c0\u30fc\u306e\u305f\u3081\u306e\u6226\u7565\u7684\u7d4c\u8def**
\n\u696d\u754c\u30ea\u30fc\u30c0\u30fc\u306f\u3001\u95a2\u7a0e\u3078\u306e\u9732\u51fa\u3092\u8efd\u6e1b\u3059\u308b\u305f\u3081\u306b\u3001API\u8abf\u9054\u3092\u591a\u69d8\u5316\u3057\u3001\u7c73\u56fd\u3092\u62e0\u70b9\u3068\u3059\u308b\u53d7\u8a17\u88fd\u9020\u7d44\u7e54\u3068\u306e\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u6a21\u7d22\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u30ec\u30b8\u30ea\u30a8\u30f3\u30b9\u3092\u512a\u5148\u3059\u3079\u304d\u3067\u3059\u3002\u540c\u6642\u306b\u3001\u6a19\u7684\u578b\u6297\u708e\u75c7\u5264\u304a\u3088\u3073\u514d\u75ab\u8abf\u7bc0\u7814\u7a76\u3078\u306e\u6295\u8cc7\u3092\u52a0\u901f\u3059\u308b\u3053\u3068\u3067\u3001\u9032\u5316\u3059\u308b\u708e\u75c7\u6027\u75be\u60a3\u30d1\u30e9\u30c0\u30a4\u30e0\u306b\u5408\u81f4\u3059\u308b\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u78ba\u4fdd\u3067\u304d\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u898f\u5236\u5f53\u5c40\u3068\u306e\u5354\u529b\u67a0\u7d44\u307f\u3092\u78ba\u7acb\u3059\u308b\u3053\u3068\u3067\u3001JAK\u963b\u5bb3\u5264\u3084PDE4\u6a19\u7684\u30d5\u30a9\u30fc\u30e0\u306a\u3069\u306e\u65b0\u898f\u30e2\u30c0\u30ea\u30c6\u30a3\u306e\u627f\u8a8d\u7d4c\u8def\u304c\u5408\u7406\u5316\u3055\u308c\u307e\u3059\u3002<\/p>\n

\u4e26\u884c\u3057\u3066\u3001\u5f37\u5316\u3055\u308c\u305f\u30c7\u30b8\u30bf\u30eb\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u30c4\u30fc\u30eb\u3084\u9060\u9694\u533b\u7642\u306e\u7d71\u5408\u3092\u542b\u3080\u30aa\u30e0\u30cb\u30c1\u30e3\u30cd\u30eb\u6d41\u901a\u6226\u7565\u3092\u80b2\u6210\u3059\u308b\u3053\u3068\u306f\u3001\u60a3\u8005\u306e\u30a2\u30af\u30bb\u30b9\u3092\u62e1\u5927\u3057\u3001\u30a2\u30c9\u30d2\u30a2\u30e9\u30f3\u30b9\u3092\u5411\u4e0a\u3055\u305b\u307e\u3059\u3002\u30ea\u30fc\u30c0\u30fc\u306f\u307e\u305f\u3001\u591a\u69d8\u306a\u60a3\u8005\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u306b\u3001\u30d7\u30ec\u30df\u30a2\u30e0\u3067\u9ad8\u6709\u52b9\u6027\u306e\u88fd\u54c1\u3068\u4fa1\u5024\u91cd\u8996\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u306e\u30d0\u30e9\u30f3\u30b9\u3092\u3068\u308b\u968e\u5c64\u578b\u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u691c\u8a0e\u3059\u3079\u304d\u3067\u3059\u3002\u6700\u5f8c\u306b\u3001\u5e02\u8ca9\u5f8c\u8abf\u67fb\u3067\u5b9f\u4e16\u754c\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u3068\u60a3\u8005\u5831\u544a\u30a2\u30a6\u30c8\u30ab\u30e0\u3092\u6d3b\u7528\u3059\u308b\u3053\u3068\u306f\u3001\u652f\u6255\u8005\u3068\u306e\u4ea4\u6e09\u3092\u5f37\u5316\u3057\u3001\u5dee\u5225\u5316\u3055\u308c\u305f\u4fa1\u5024\u63d0\u6848\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3001\u9577\u671f\u7684\u306a\u6301\u7d9a\u53ef\u80fd\u6027\u3068\u5e02\u5834\u30b7\u30a7\u30a2\u306e\u7372\u5f97\u3092\u5f37\u5316\u3057\u307e\u3059\u3002<\/p>\n

\u3053\u306e\u5305\u62ec\u7684\u306a\u5206\u6790\u306f\u3001\u8102\u6f0f\u6027\u76ae\u819a\u708e\u6cbb\u7642\u5e02\u5834\u306e\u8907\u96d1\u306a\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3092\u6df1\u304f\u7406\u89e3\u3057\u3001\u5c06\u6765\u306e\u6210\u9577\u3068\u9769\u65b0\u306e\u305f\u3081\u306e\u6226\u7565\u7684\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/50525"}],"collection":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/comments?post=50525"}],"version-history":[{"count":2,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/50525\/revisions"}],"predecessor-version":[{"id":51552,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/posts\/50525\/revisions\/51552"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/media?parent=50525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/categories?post=50525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.jp\/reports\/wp-json\/wp\/v2\/tags?post=50525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}